News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News August 27, 2025
Gibson Dunn Advised Ad Hoc Group of Lenders in City Brewing’s Strategic Debt Reduction and Investment Transaction
Gibson Dunn advised an ad hoc group of lenders in connection with City Brewing Company LLC’s fully consensual strategic transaction to reduce its debt and secure new capital investment.
Accolades August 27, 2025
Russell Balikian Among Top 25 Telecommunications Attorneys of 2025
Partner Russell Balikian has been named by Attorney Intel as one of the Top 25 Telecommunications Attorneys of 2025
Firm News August 27, 2025
Gibson Dunn Advised Carlyle on Acquisition of intelliflo from Invesco
Gibson Dunn advised Carlyle, a global investment firm, on its acquisition of cloud-based practice management software provider intelliflo from global asset management firm Invesco
Firm News August 26, 2025
Gibson Dunn Advises Royalty Pharma on Acquisition of Royalty Interest in Amgen’s Imdelltra
Gibson Dunn is representing Royalty Pharma plc in its acquisition of a royalty interest in Amgen’s Imdelltra, a first-in-class DLL3 targeting bispecific T-cell engager (BiTE), from BeOne Medicines for up to $950 million.
Firm News August 26, 2025
Gibson Dunn Expands Premier Antitrust Practice with Brussels Partner Adam Dawson
Gibson Dunn announced today that Adam Dawson has joined the firm’s Brussels office as a partner in its Antitrust and …
Firm News August 25, 2025
Gibson Dunn Represented Houlihan Lokey, Financial Advisor to Vital Energy in Vital’s $3.1 Billion Merger with Crescent Energy
Gibson Dunn served as counsel to Houlihan Lokey, which acted as financial advisor to Vital Energy, Inc. and delivered a fairness opinion to the board of directors in Vital’s merger with Crescent Energy Company.
Firm News August 25, 2025
Gibson Dunn Advises PatientPoint, L Catterton, and Littlejohn in PatientPoint’s Sale to Advent International
Gibson Dunn is advising PatientPoint, L Catterton, and Littlejohn & Co., LLC in PatientPoint’s sale to Advent International from an investor group led by L Catterton and Littlejohn.
In the Media August 22, 2025
Shukie Grossman Discusses Proposed Changes to Retirement Plan Investment Options with Law360
In an extensive interview with Law360 (subscription required) about President Trump’s executive order seeking to reduce regulatory obstacles to retirement plans investing in alternative assets such as private equity, real estate, and cryptocurrency, New York partner Shukie Grossman noted that "The democratization of private equity is a hot topic mainly because the private equity industry and its adjacencies have generated returns which by and large have exceeded public market returns.”